GILARD, Martine, Michael SCHLÜTER, Thomas M. SNOW, Gianni DALL´ARA, Helene ELTCHANINOFF, Neil MOAT, Javier GOICOLEA, Gian Paolo USSIA, Petr KALA, Peter WENAWESER, Marian ZEMBALA, Georg NICKENIG, Susanna PRICE, Eduardo Alegria BARRERO, Bernard IUNG, Pepe ZAMORANO, Gerhard SCHULER, Roberto CORTI, Ottavio ALFIERI, Bernard PRENDERGAST, Peter LUDMAN, Stephan WINDECKER, Manel SABATE, Adam WITKOWSKI, Haim DANENBERG, Ervin SCHROEDER, Francesco ROMEO, Carlos MACAYA, Geneviève DERUMEAUX, Cécile LAROCHE, Michele PIGHI, Roberta SERDOZ and Carlo Di MARIO. The 2011-2012 pilot European Society of Cardiology Sentinel Registry of Transcatheter Aortic Valve Implantation: 12-month clinical outcomes. Eurointervention. Toulouse: Europa edition, 2016, vol. 12, No 1, p. 79-87. ISSN 1774-024X. Available from: https://dx.doi.org/10.4244/EIJV12I1A15.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name The 2011-2012 pilot European Society of Cardiology Sentinel Registry of Transcatheter Aortic Valve Implantation: 12-month clinical outcomes
Authors GILARD, Martine (250 France), Michael SCHLÜTER (276 Germany), Thomas M. SNOW (826 United Kingdom of Great Britain and Northern Ireland), Gianni DALL´ARA (826 United Kingdom of Great Britain and Northern Ireland), Helene ELTCHANINOFF (250 France), Neil MOAT (826 United Kingdom of Great Britain and Northern Ireland), Javier GOICOLEA (724 Spain), Gian Paolo USSIA (380 Italy), Petr KALA (203 Czech Republic, guarantor, belonging to the institution), Peter WENAWESER (756 Switzerland), Marian ZEMBALA (616 Poland), Georg NICKENIG (276 Germany), Susanna PRICE (826 United Kingdom of Great Britain and Northern Ireland), Eduardo Alegria BARRERO (724 Spain), Bernard IUNG (250 France), Pepe ZAMORANO (724 Spain), Gerhard SCHULER (276 Germany), Roberto CORTI (756 Switzerland), Ottavio ALFIERI (380 Italy), Bernard PRENDERGAST (826 United Kingdom of Great Britain and Northern Ireland), Peter LUDMAN (826 United Kingdom of Great Britain and Northern Ireland), Stephan WINDECKER (756 Switzerland), Manel SABATE (724 Spain), Adam WITKOWSKI (616 Poland), Haim DANENBERG (376 Israel), Ervin SCHROEDER (56 Belgium), Francesco ROMEO (380 Italy), Carlos MACAYA (724 Spain), Geneviève DERUMEAUX (250 France), Cécile LAROCHE (250 France), Michele PIGHI (826 United Kingdom of Great Britain and Northern Ireland), Roberta SERDOZ (826 United Kingdom of Great Britain and Northern Ireland) and Carlo Di MARIO (826 United Kingdom of Great Britain and Northern Ireland).
Edition Eurointervention, Toulouse, Europa edition, 2016, 1774-024X.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30201 Cardiac and Cardiovascular systems
Country of publisher France
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 5.193
RIV identification code RIV/00216224:14110/16:00092745
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.4244/EIJV12I1A15
UT WoS 000379196400016
Keywords in English aortic stenosis; registry; survival; transcatheter aortic valve implantation (TAVI)
Tags EL OK
Tags International impact, Reviewed
Changed by Changed by: Ing. Mgr. Věra Pospíšilíková, učo 9005. Changed: 9/2/2017 10:16.
Abstract
Aims: Our aim was to assess one-year outcomes of patients enrolled in the pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation (TAVI). Methods and results: One-year outcomes of 4,571 patients (81.4 +/- 7.2 years, 2,291 [50.1%] male) receiving TAVI with the SAPIEN XT (57.3%) or CoreValve prosthesis at 137 European centres were analysed using Kaplan-Meier and Cox proportional hazards regression techniques. At one year, 3,341 patients were alive, 821 had died, and 409 were lost to follow-up. Of 2,125 patients who underwent functional assessment, 1,916 (90%) were in New York Heart Association (NYHA) Class I/II at one year, with functional improvement from baseline noted in 1,682 patients (88%). One-year survival based on 4,564 patients was estimated at 79.1%. Independent baseline predictors of mortality were increasing age and logistic EuroSCORE, the presence of NYHA III/IV, chronic obstructive pulmonary disease, and atrial fibrillation. Female gender was associated with a 4% survival benefit at one year. Vascular access routes other than transfemoral were associated with poorer survival. Procedural failure and major periprocedural complications had an adverse impact on survival. Conclusions: Contemporary European experience attests to the effectiveness of routine TAVI in unelected elderly patients.
PrintDisplayed: 7/10/2024 06:30